Clinical effect of cetirizine hydrochloride, calcium gluconate and vitamin C in treating  acute or chronic urticaria

XU Wen; XIA Yunkun

PDF(535 KB)

Medical Journal of the Chinese People Armed Police Forces ›› 2017, Vol. 28 ›› Issue (12) : 1202-1204.

ORIGINAL ARTICLES

Clinical effect of cetirizine hydrochloride, calcium gluconate and vitamin C in treating acute or chronic urticaria

XU Wen, XIA Yunkun

Author information +

History +

Abstract

Objective To observe the clinical effect of cetirizine hydrochloride combined with calcium gluconate and vitamin C in the treatment of acute or chronic urticaria.Methods One hundred and twenty patients with acute or chronic urticaria were treated with cetirizine hydrochloride, calcium gluconate and vitamin C. The therapeutic effect, rate of recurrence, clinical symptoms integral before and after treatment, immunoglobulin E (IgE), quality of life and adverse reactions were observed.Results The total effective rate was 95.00% in patients with acute or chronic urticaria, and the recurrence rate was 3.33%. IgE, the duration, number, diameter, appearance and frequency of onsets of wheals , the degree of pruritus, and scores of quality of life were all lower after treatment(P<0.05). There were no adverse reactions during the medication.Conclusions Cetirizine hydrochloride combined calcium gluconate and vitamin C in the treatment of acute or chronic urticaria is effective, which can mitigate clinical symptoms and reduce the serum concentration of IgE.

Key words

acute or chronic urticaria / cetirizine hydrochloride / calcium gluconate / vitamin C

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

XU Wen, XIA Yunkun. Clinical effect of cetirizine hydrochloride, calcium gluconate and vitamin C in treating acute or chronic urticaria[J]. Medical Journal of the Chinese People Armed Police Forces. 2017, 28(12): 1202-1204

References

[1] Metz M, Staubach P, Bauer A,et al. Clinical efficacy of omalizumab in chronic spontaneous urticaria is associated with a reduction of FcεRI-positive cells in the skin[J]. Theranostics,2017,7(5):1266-1276.
[2] Woo Y R, Jung K E, Koo D W, et al. Vitamin D as a Marker for disease severity in chronic urticaria and its possible role in pathogenesis[J]. Ann Dermatol, 2015,27(4):423-430.
[3] Rasool R, Masoodi K Z, Shera I A, et al. Chronic urticaria merits serum vitamin D evaluation and supplementation; a randomized case control study[J]. World Allergy Organ J,2015,8(1):15.
[4] 巫艳芬,王玉梅,王永华,等.盐酸异丙嗪片与盐酸西替利嗪片联合治疗慢性荨麻疹的疗效观察[J]. 中国医药科学, 2017, 7(1):81-83.
[5] 周韶玮.盐酸左西替利嗪联合卡介菌多糖核酸治疗慢性荨麻疹的疗效观察[J]. 四川医学, 2012,33(12):2196-2197.
[6] 刘斌,陈艳香,陈军秀,等.抗敏合剂联合盐酸左西替利嗪治疗慢性荨麻疹的疗效观察[J]. 中国药房, 2012,23(48):4578-4580.
[7] 孙静,崔蓉,李乐平.西替利嗪治疗慢性荨麻疹的临床疗效观察[J].重庆医学, 2013, 42(16):1822-1823.
[8] 张丽萍,关爽.荨麻疹的诊治[J]. 中国社区医师, 2003,19(13):21.
[9] 徐金华. 2007版中国慢性荨麻疹诊疗指南解读[C]. 2008全国中西医结合皮肤性病学术会议. 2008.
[10] Arik Yilmaz E, Karaatmaca B, Cetinkaya P G, et al. The persistence of chronic spontaneous urticaria in childhood is associated with the urticariaactivity score[J]. Allergy Asthma Proc,2017,38(2):136-142.
[11] Soria A, Francès C. Urticaria: diagnosis and treatment[J]. Rev Med Interne, 2014,25(14):30-37.
[12] 廖卫宁.盐酸左西替利嗪联合注射复方甘草酸苷治疗慢性荨麻疹的疗效观察 [J].北方药业,2012,9(3):19.
[13] Criado P R, Criado R F, Takakura C F. Ultrastructure of vascular permeability in urticaria[J]. Isr Med Assoc J, 2013,15(4):173-177.
[14] Kumaran M S, Mangal S, Narang T, et al. Autologous serum and plasma skin tests in chronic spontaneous urticaria: a reappraisal[J]. Indian Dermatol Online J, 2017,8(2):94-99.
[15] Zazzali J L, Kaplan A, Maurer M, et al. Importance of angioedema-free days in patients with chronic idiopathic or spontaneous urticaria[J]. Ann Allergy Asthma Immunol, 2017,118(4):524.
[16] Lee S J, Ha E K, Jee H M,et al.Prevalence and risk factors of urticaria with a focus on chronic urticaria in children[J]. Allergy Asthma Immunol Res,2017,9(3):212-219.
[17] Yan S, Chen W, Su J,et al. Association between C reactive protein and clinical characteristics in patients with chronic spontaneous urticaria[J]. Zhong Nan Da Xue Xue Bao Yi Xue Ban,2017,42(2):168-172.
[18] Tonacci A, Billeci L, Pioggia G, et al. Omalizumab for the treatment of chronic idiopathic urticaria: systematic review of the literature[J]. Pharmacotherapy,2017,37(4):464-480.
[19] Costa C, Gonçalo M, GPEU - Grupo Português de Estudos de Urticária. Diagnostic and therapeutic approach of chronic spontaneous urticaria: recommendations in portugal[J].Acta Med Port,2016,29(11):763-781.
[20] Asero R, Marzano A V, Ferrucci S,et al. D-Dimer plasma levels parallel the clinical response to omalizumab in patients with severe chronic spontaneous urticaria[J].Int Arch Allergy Immunol,2017,172(1):40-44.
[21] Huang X, Li Z, Sun R. Synergistic actions of histamine-releasing factor and histamine releasing factor-reactive IgE in chronic urticaria[J]. Int Arch Allergy Immunol, 2017,172(1):27-32.
[22] Quirk S K, Rainwater E, Shure A K,et al. Vitamin D in atopic dermatitis, chronic urticaria and allergic contact dermatitis[J]. Expert Rev Clin Immunol,2016,12(8):839-847.
[23] 石春蕊,陈康兵,王敏,等.中药当归饮子联合盐酸西替利嗪治疗慢性荨麻疹的疗效观察[J].中国全科医学,2013,16(40):4102-4105.
[24] 栾红,王英杰,孟宪敏.卡介菌多糖核酸联合西替利嗪、雷尼替丁治疗慢性荨麻疹的疗效及与血清IgE水平的关系[J]. 山东医药, 2011,51(23):62-63.
[25] 毕超,梁艳华,黎小东,等.慢性荨麻疹患者食物过敏原特异性IgG、IgE检测结果分析[J]. 国际检验医学杂志,2012,33(1):7-9.